Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients

Maristella Pitzalis(Institute of Genetic and Biomedical Research), Francesco Cucca(University of Sassari), Francesca Virdis(Institute of Genetic and Biomedical Research), Maristella Steri(Institute of Genetic and Biomedical Research), Annalisa Loizedda(Institute of Genetic and Biomedical Research), Monia Lobina(Institute of Genetic and Biomedical Research), Federica Loi(Istituto Zooprofilattico Sperimentale della Sardegna), M. Marini(Institute of Genetic and Biomedical Research), Jessica Frau(University of Cagliari), Paolo Solla(University of Sassari), Lorena Lorefice(University of Cagliari), Matteo Floris(University of Sassari), Valeria Lodde(University of Sassari), Daniele Carmagnini(University of Cagliari), Valeria Orrù(Institute of Genetic and Biomedical Research), Maura Mingoia(Institute of Genetic and Biomedical Research), Marzia Fronza(University of Cagliari), Giuseppe Delogu(Sapienza University of Rome), Elisa Carta(University of Cagliari), Maria Laura Idda(University of Cambridge), Marcella Devoto(Children's Hospital of Philadelphia), Sergio Uzzau(University of Sassari), Federica Pirinu(University of Sassari), Eleonora Cocco(University of Cagliari), Ignazio Roberto Zarbo(University of Sassari), Edoardo Fiorillo(Institute of Genetic and Biomedical Research), Magdalena Żołędziewska(Institute of Genetic and Biomedical Research)
Frontiers in Immunology
December 9, 2021
Cited by 57


Related Papers